Study Name:

 Phase II Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy Plus Dasatinib (NSC #732517, IND #73969) and Continuation Therapy With Dasatinib Alone in Newly Diagnosed Patients With Core Binding Factor Acute Myeloid Leukemia (AML).

         

Purpose:

This phase II trial is studying the side effects and how well giving combination chemotherapy together with dasatinib works in treating patients with newly diagnosed acute myeloid leukemia.

Study Type: Treatment

Protocol: UIC 2011-0863 CALGB 10801

 

For study details, click here.

Internal users only: click here for protocol details and forms

Study Name:

Assessment of Novel Molecular Markers in Acute Myeloid Leukemia.

 

         

Purpose:

This research study is looking at tissue and blood samples from patients with acute myeloid leukemia.

Study Type: Observational

Protocol: UIC 2010-0368 CALGB 20202

 

For study details, click here.

Internal users only: click here for protocol details and forms

Study Name:

Molecular Genetic Features of Acute Lymphoblastic Leukemia

         

Purpose:

Diagnostic study of genetic markers in adult patients who have acute lymphoblastic leukemia or acute promyelocytic leukemia.

Study Type: Diagnostic

Protocol: UIC 2004-0712 CALGB 9862

 

For study details, click here.

Internal users only: click here for protocol details and forms

Study Name:

Cytogenetic Studies For Previously Untreated AML, ALL or MDS Patients (Companion To CALGB Treatment Studies For Previously Untreated AML, ALL Or MDS Patients).

         

Purpose:

This diagnostic trial is studying genetic differences in patients with treated and untreated acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, or multiple myeloma.

Study Type: Diagnostic

Protocol: UIC 1996-0603 CALGB 8461

 

For study details, click here.

Internal users only: click here for protocol details and forms

Study Name:

The CALGB Leukemia Tissue Bank

         

Purpose:

This laboratory study is collecting and storing blood, bone marrow, and other samples from patients with acute leukemia, chronic leukemia, or myelodysplastic syndromes.

Study Type: Observational

Protocol: UIC 1996-0806 CALGB 9665

 

For study details, click here.

Internal users only: click here for protocol details and forms

Back to Oncology Clinical Trials Homepage